1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
First-line Treatment with RC48 Plus Tislelizumab and S-1(RCTS) in Advanced Gastric CancerHER2-positive Gastric CancerActive, not recruitingPhase 22025-02-07NCT05586061